Asston Pharmaceuticals SME
smeListed
GMP
₹26
smeListed
Asston Pharmaceuticals SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹26
(+21.14%) Est. Gain
Investment Timeline
✓
IPO Open
9 Jul 2025
✓
IPO Close
11 Jul 2025
✓
Allotment
14 Jul 2025
✓
Listing
16 Jul 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
CONSIDER APPLYING
62.5/100
🎯 Application Strategy
Action: 👍 CONSIDER - Decent opportunity for diversification
Lots: Apply 1-2 lots based on risk appetite
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
📈 Moderate listing gains possible (5-12%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹115.00-123.00
📦Lot Size
1000 shares
💰Issue Size
₹26.17 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Asston Pharmaceuticals SME?
As of today, the Grey Market Premium (GMP) for Asston Pharmaceuticals SME is ₹26, which is approximately (+21.14%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Asston Pharmaceuticals SME?
Our AI algorithm currently rates this IPO as "CONSIDER APPLYING" with a score of 62.5/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Asston Pharmaceuticals SME be announced?
The allotment status for Asston Pharmaceuticals SME is expected to be finalized on 14 Jul 2025. Investors can check their status on the registrar's website.
What is the listing date for Asston Pharmaceuticals SME?
Shares of Asston Pharmaceuticals SME are proposed to be listed on stock exchanges on 16 Jul 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.